Activation of the PI3K/mTOR/AKT Pathway and Survival in Solid Tumors: Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

Activation of the PI3K/mTOR/AKT Pathway and Survival in Solid Tumors: Systematic Review and Meta-Analysis

Published:2014-04-28 Issue:4 Volume:9 Page:e95219
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ocana Alberto,Vera-Badillo Francisco,Al-Mubarak Mustafa,Templeton Arnoud J.,Corrales-Sanchez Verónica,Diez-Gonzalez Laura,Cuenca-Lopez María D.,Seruga Bostjan,Pandiella Atanasio,Amir Eitan

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference40 articles.

1. Oncogenic targets, magnitude of benefit, and market pricing of antineoplastic drugs;E Amir;J Clin Oncol,2011

2. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2;DJ Slamon;N Engl J Med,2001

3. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial;YJ Bang;Lancet,2010

4. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia;SG O'Brien;N Engl J Med,2003

5. Improved survival with vemurafenib in melanoma with BRAF V600E mutation;PB Chapman;N Engl J Med,2011

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FGA influences invasion and metastasis of hepatocellular carcinoma through the PI3K/AKT pathway;Aging;2024-07-09

2. PIWI-interacting RNAs (PiRNAs) as emerging biomarkers and therapeutic targets in biliary tract cancers: A comprehensive review;Heliyon;2024-07

3. Targeting PI3K/AKT/mTOR signaling to overcome drug resistance in cancer;Chemico-Biological Interactions;2024-06

4. Cervical Cancer With The Active And Stable PI3K/MTOR/AKT Pathway In Azerbaijan Patients;Journal of Cervical Cancer;2024-03-02

5. The interplay of PTEN and AKT nexus in breast cancer: a molecular perspective;Molecular Biology Reports;2024-02-24